William Rosser Berry, MD

Publications

Solsky, Ian, William Berry, Lizabeth Edmondson, Janaka Lagoo, Joshua Baugh, Alex Blair, Sara Singer, and Alex B. Haynes. “World Health Organization Surgical Safety Checklist Modification: Do Changes Emphasize Communication and Teamwork?.” J Surg Res 246 (February 2020): 614–22. https://doi.org/10.1016/j.jss.2018.09.035.

PMID
30528925
Full Text

Lagoo, Janaka, Robbie Singal, William Berry, Atul Gawande, Christine Lim, Sompob Paibulsirijit, and Joaquim Havens. “Development and Feasibility Testing of a Device Briefing Tool and Training to Improve Patient Safety During Introduction of New Devices in Operating Rooms: Best Practices and Lessons Learned..” J Surg Res 244 (December 2019): 579–86. https://doi.org/10.1016/j.jss.2019.05.056.

PMID
31446322
Full Text

Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer..” Cancer Med 8, no. 10 (August 2019): 4644–55. https://doi.org/10.1002/cam4.2375.

PMID
31270961
Full Text

Lagoo, Janaka, William R. Berry, Kate Miller, Brandon J. Neal, Luke Sato, Keith D. Lillemoe, Gerard M. Doherty, et al. “Multisource Evaluation of Surgeon Behavior Is Associated With Malpractice Claims..” Ann Surg 270, no. 1 (July 2019): 84–90. https://doi.org/10.1097/SLA.0000000000002742.

PMID
29578910
Full Text

Massard, Christophe, Margitta Retz, Peter Hammerer, Fernando Quevedo, Peter C. C. Fong, William R. Berry, Howard Gurney, et al. “Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort B of the phase 1b/2 KEYNOTE-365 study..” In Journal of Clinical Oncology, 37:5029–5029. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5029.

Full Text

Fong, Peter C. C., Margitta Retz, Alexandra Drakaki, Christophe Massard, William R. Berry, Emanuela Romano, Johann S. De Bono, et al. “Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort C of the phase 1b/2 KEYNOTE-365 study..” In Journal of Clinical Oncology, 37:5010–5010. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5010.

Full Text

Berry, William R., Christopher Michael Pieczonka, Nicholas J. Vogelzang, Lawrence Ivan Karsh, James L. Bailen, Krista Van Velzen, Harini Kandadi, Nadeem Anwar Sheikh, and Shaker R. Dakhil. “Antigen (Ag) spread after sipuleucel-T and correlation with overall survival (OS): A real-world experience..” In Journal of Clinical Oncology, 37:e16504–e16504. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.e16504.

Full Text

Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study..” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.

PMID
30865549
Full Text

Petrylak, Daniel P., Philip Kantoff, Nicholas J. Vogelzang, Anthony Mega, Mark T. Fleming, Joe J. Stephenson, Richard Frank, et al. “Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer..” Prostate 79, no. 6 (May 2019): 604–13. https://doi.org/10.1002/pros.23765.

PMID
30663074
Full Text

Tucker, Matthew D., Jason Zhu, William R. Berry, Sundhar Ramalingam, Tian Zhang, Michael Roger Harrison, Yuan Wu, Patrick Healy, Daniel J. George, and Andrew J. Armstrong. “Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC)..” In Journal of Clinical Oncology, 37:172–172. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.172.

Full Text

Pages